Related Experiment Video
Updated: Jul 13, 2026
06:31
Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
Plasma cytokine levels in ulcerative colitis
Vedat Goral1, Tahir Celenk, Abdurahman Kaplan
1Department of Gastroenterology, Dicle University School of Medicine, Diyarbakir, Turkey. vegoral@hotmail.com
Hepato-Gastroenterology
|July 17, 2007
Summary
Certain cytokines, including IL-2Rsp, IL-6, IL-8, and IL-10, are key in ulcerative colitis (UC) development. These inflammatory markers may aid in UC diagnosis, treatment, and prognosis.
Area of Science:
- Immunology
- Gastroenterology
Background:
- Immunological factors contribute to ulcerative colitis (UC) pathogenesis.
- Cytokines are implicated in the inflammatory processes of UC.
Purpose of the Study:
- To investigate the role of specific cytokines in UC.
- To identify potential diagnostic and prognostic markers for UC.
Main Methods:
- Comparative analysis of cytokine levels in 20 UC patients and 20 healthy controls.
- Measurement of Interleukin-2 receptor soluble peptide (IL-2Rsp), IL-6, IL-8, IL-10, TNF-alpha, and IL-1 beta levels.
Main Results:
- Significant differences in IL-2Rsp, IL-6, IL-8, and IL-10 levels were observed between UC patients and controls (p < 0.005).
- Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-1 beta (IL-1 beta) levels were similar in both groups.
Conclusions:
- IL-2Rsp, IL-6, IL-8, and IL-10 are crucial in UC pathogenesis.
- These cytokines show promise as biomarkers for UC diagnosis, treatment monitoring, and prognosis.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...